Podcast

MPR Weekly Dose Podcast Episode 112

A second booster dose for some COVID-19 vaccines is authorized; Sotrovimab has its use limited due to the BA.2 Omicron subvariant; An investigational oral antiviral gains Fast Track designation; PreHevbrio hepatitis B vaccine now available; And the FDA update a safety communication regard the risk of thyroid dysfunction in infants following the use of contrast…

MPR Weekly Dose Podcast Episode 111

Allergy treatment gets over-the-counter approval; Anaphylaxis treatment recalled; Phase 3 trial results for investigational sciatica treatment; FDA alert regarding at-home COVID-19 tests; And the resubmitted Biologics License Application for teplizumab for type 1 diabetes is accepted. 

MPR Weekly Dose #110: Interview With Dr Tobias Janowitz

Subscribe: Apple Podcasts | Deezer | Spotify | Stitcher In this week’s special episode of The Weekly Dose Podcast we interview Dr Tobias Janowitz, a medical oncologist, assistant professor at the Cold Spring Harbor Laboratories and adjunct professor at the Feinstein Institutes. Dr Janowitz was part of a team that recently conducted a phase 2…

MPR Weekly Dose Podcast Episode 109

A new injection is approved for opioid overdoses; The Advisory Committee on Immunization Practices releases vaccine schedules; The FDA provides a list of approved COVID-19 tests; A trial of an investigational spontaneous urticaria treatment is stopped; And the first condom is authorized for anal intercourse.

MPR Weekly Dose Podcast Episode 108

This week: in COVID related news, a heartburn medication shows benefits; Bebtelovimab is authroized; Veklury is shown to retain antiviral activity against variants. Away from COVID, a functionally scored carbidopa/levodopa tablet is now available for Parkinson disease, and the FDA issues an alert regarding ketamine compounding.

MPR Weekly Dose Podcast Episode 107

This week: millions of courses of a COVID-19 oral antiviral was provided to the US government for distribution throughout the country; There’s a draft guidance for novel nonopioid analgesics; Possible strangulation warning for enteral feeding tubes; A new treatment has been approved for cold agglutinin disease; And a treatment is under review for HFrEF.

MPR Weekly Dose Podcast Episode 106

This week: The approval of a second COVID-19 vaccine; Pfizer and BioNTech submit for Emergency Use of their vaccine for children under 5; Pfizer also stop development on a potential drug treatment to reduce cardiovascular risk and severe hypertriglyceridemia; And a HIV drug gets new dosing option.